This article determines the incidence and cause of the complications commonly associated with metal-on-metal hip resurfacing implants and the proposed methods to prevent these complications. The literature available in PubMed was reviewed. Complication rates after hip resurfacing are low, and the procedure has shown both safety and efficacy in the hands of surgeons trained in specialized centers. Proper surgical technique can further reduce the incidence of femoral neck fracture, component loosening, and abnormal wear of the prosthesis. A more systematic detection of adverse local tissue reactions is needed to provide accurate assessments of their prevalence.
The new generation of hip metal-on-metal resurfacing arthroplasty (MMRA) devices have now been implanted for more than 13 years in the centers that initiated the return to this procedure. Ten-year survivorship data for MMRA are currently being reported in international meetings, with the first publication of the results of 100 hips at 10 to14 years showing an 88.5% survival rate (95% confidence interval, 80.2%–93.5%) and 100% in 28 hips with ideal bone (cysts <1 cm and component size >46). These results represent a dramatic improvement over metal/polyethylene hip resurfacing introduced in the mid-1970s and are comparable to total hip replacement (THR) survivorship in the Swedish registry for young patients implanted during the same period, before the introduction of alternate bearings. During this period, an array of complications specific to hip resurfacing has been identified, and solutions to prevent these complications have been proposed with varying degrees of success. The cause of most complications is usually multifactorial and falls under the broad categories of patient selection, prosthetic design, and surgical technique.
This article determines the incidence and cause of the complications commonly associated with MMRA, as well as the proposed methods and their success in preventing those complications. A comprehensive review of the published literature related to MMRA of the hip was undertaken to this effect.
Search strategy and criteria
A systematic review of the available literature was performed to identify publications related to hip resurfacing arthroplasty. An electronic search of MEDLINE was conducted using the search engine of the US National Library of Medicine. We searched for articles published after January 1, 2000, in the English language. Alternate keywords such as surface arthroplasty and surface replacement were added to the search because the term resurfacing, now predominantly accepted to describe the procedure, was not used systematically until after a sizable part of the related literature had already been published. We excluded expert opinions and editorial publications. We retained the studies that provided information about the incidence, etiology, or prevention of the type of complication reviewed in each subsection. Finally, we searched for relevant work in the bibliographies provided in recent review articles to identify additional studies that did not appear in the systematic search.
Femoral neck fracture
Incidence of Femoral Neck Fractures
To assess the worldwide incidence of femoral neck fracture after modern hip resurfacing, we collected data from the reports providing this information since 2005 and selected the most recent when several reports were published based on the same series of patients. Our computations yielded a 1.69% incidence of femoral neck fracture (range, 0%–9.2%) for a global cohort of 10,381 cases, including 3497 from the Australian Hip Registry ( Table 1 ).
Authors | Journal | Year | Implant | Surgeons | Number of Hips | Number of Neck Fractures | Percentage |
---|---|---|---|---|---|---|---|
Madhu et al | J Arthroplasty | 2010 | BHR | 1 surgeon | 117 | 5 | 4.3 |
Jameson et al | J Bone Joint Surg Br | 2010 | ASR | 1 surgeon | 214 | 4 | 1.9 |
Ollivere et al | Int Orthop | 2009 | BHR | 1 surgeon | 104 | 0 | 0 |
Khan et al | J Arthroplasty | 2009 | BHR | Multicenter | 679 | 11 | 1.6 |
Beaulé et al | J Arthroplasty | 2009 | Conserve® Plus | 1 surgeon | 116 | 0 | 0 |
O’Neill et al | Bull of NYU Hosp Jt Dis | 2009 | 5 designs | Multicenter | 250 | 4 | 1.6 |
Steffen et al | J Arthroplasty | 2009 | 4 designs | 5 surgeons | 842 | 15 | 1.8 |
Amstutz and Le Duff | J Arthroplasty | 2008 | Conserve® Plus | 1 surgeon | 1000 | 10 | 1.0 |
Della Valle et al | Clin Orthop Relat Res | 2008 | BHR | Multicenter | 537 | 10 | 1.9 |
Heilpern et al | J Bone Joint Surg Br | 2008 | BHR | 1 surgeon | 110 | 1 | 0.9 |
Kim et al | J of Arthroplasty | 2008 | Conserve® Plus | Multicenter | 200 | 2 | 1.0 |
Witzleb et al | Eur J Med Res | 2008 | BHR | 1 surgeon | 300 | 1 | 0.3 |
McAndrew et al | Hip Int | 2007 | BHR | Multicenter | 180 | 8 | 2.2 |
Mont et al | Clin Orthop Relat Res | 2007 | Conserve® Plus | Multicenter | 1016 | 27 | 2.7 |
Marker et al | J Arthroplasty | 2007 | Conserve® Plus | 1 surgeon | 550 | 14 | 2.5 |
Nishii et al | J Arthroplasty | 2007 | BHR | 1 surgeon | 50 | 1 | 2.0 |
Siebel et al | JEIM | 2006 | ASR | 1 surgeon | 300 | 5 | 1.7 |
Vail et al | Clin Orthop Relat Res | 2006 | Conserve® Plus | 1 surgeon | 57 | 1 | 1.8 |
Pollard et al | J Bone Joint Surg Br | 2006 | BHR | 1 surgeon | 63 | 3 | 4.8 |
Shimmin & Back | J Bone Joint Surg Br | 2005 | BHR | Multicenter | 3497 | 50 | 1.4 |
Treacy et al | J Bone Joint Surg Br | 2005 | BHR | 1 surgeon | 144 | 1 | 0.7 |
Cutts et al | Hip Int | 2005 | Cormet | 5 surgeons | 65 | 6 | 9.2 |
Total | — | — | — | — | 10,381 | 175 | 1.69 |